CellMax Life
Pre-clinicalCurrent non-invasive screening options miss most adenomas. They are ineffective for prevention.
Founded
2014
Focus
Diagnostics
About
Current non-invasive screening options miss most adenomas. They are ineffective for prevention.
Funding History
2Total raised: $48M
Series B$30MWI Harper GroupSep 15, 2020
Series A$18MTaiwan MobileMay 15, 2018
Company Info
TypePrivate
Founded2014
LocationSunnyvale, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile